What are the guidelines for using xylometazoline (decongestant) drops in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Using Xylometazoline (Decongestant) Drops in Children

Xylometazoline nasal drops should be used for no more than 3 days in children to prevent rhinitis medicamentosa, and are not recommended for children under 6 years of age due to potential toxicity. 1

Mechanism and Appropriate Use

  • Xylometazoline is an imidazoline derivative topical decongestant that causes nasal vasoconstriction and decreases nasal edema, providing temporary relief of nasal congestion 2, 1
  • Topical decongestants like xylometazoline have no effect on itching, sneezing, or nasal secretions, making them appropriate only for congestion relief 2
  • Xylometazoline is appropriate for short-term use (less than 3 days) for nasal congestion associated with acute conditions such as viral infections, exacerbations of allergic rhinitis, and Eustachian tube dysfunction 1

Duration of Use and Risk of Rhinitis Medicamentosa

  • Continuous use of topical decongestants like xylometazoline is not recommended due to the potential development of rhinitis medicamentosa (rebound nasal congestion) 2
  • Rhinitis medicamentosa may develop within 3 days of continuous use, though the development is highly variable 2, 1
  • Research has shown that sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling after 30 days of use 3
  • One study found that after 30 days of continuous use, rebound swelling occurred in eight out of nine subjects 3

Age-Specific Recommendations

  • Xylometazoline is not recommended for children under 6 years of age due to potential toxicity 1
  • For children over 6 years, the concentration and dosing should be appropriate for pediatric use 1
  • A retrospective cohort study found that low-dose xylometazoline (0.025% concentration) appeared to be safe in hospitalized infants when used at maximum three times daily, though this contradicts general recommendations against use in very young children 4

Safety Concerns and Adverse Effects

  • Case reports have documented serious adverse effects from xylometazoline overdose in children, including central nervous system depression and cardiovascular effects 5
  • A case series described three 3-year-old children who experienced unresponsiveness, bradycardia, and respiratory depression after receiving a 40-fold overdose of xylometazoline due to a compounding error 5
  • Common side effects with proper use include local stinging or burning, sneezing, and dryness of the nose and throat 2
  • More serious adverse events can include nosebleeds, which were reported as having a probable link to xylometazoline use in some cases 4

Combination Therapy

  • When severe nasal congestion is present, combining intranasal corticosteroids with xylometazoline for a few days (≤3 days) has proven benefit 2
  • For long-term management of chronic nasal congestion, intranasal corticosteroids should be used instead of topical decongestants 1
  • Xylometazoline combined with ipratropium bromide can effectively treat both nasal congestion and rhinorrhea simultaneously 6

Practical Recommendations for Use

  • Limit use to a maximum of 3 days to prevent development of rhinitis medicamentosa 2, 1
  • Use the appropriate pediatric concentration and dosage based on the child's age 1
  • Consider alternative treatments for chronic nasal congestion, such as intranasal corticosteroids, which have been shown to be more effective for long-term management 2
  • Monitor for signs of adverse effects, particularly in younger children 5
  • Ensure proper administration technique to maximize effectiveness and minimize side effects 2

Special Considerations

  • Be cautious when using xylometazoline in children with cardiovascular conditions 1
  • Avoid use in children taking medications that may interact with decongestants, such as stimulants used for ADHD management 2
  • If rhinitis medicamentosa develops, discontinue the topical decongestant and consider using intranasal corticosteroids to hasten recovery 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.